PROMOMED expands the geography of its presence: The company has opened an international division in China
27.08.2026
27.08.2026
Promomed topped the rating of pharmaceutical manufacturers in the first seven months of 2026, according to data from the analytical agency DSM Group.

© RIA Novosti / Generated by artificial intelligence Scientific laboratory. Archive photo
In monetary terms, the company's share reached 3.26%. The second place was taken by Bayer AG, the third by Nizhpharm, and the fourth by Abbott Laboratories.
Promomed has achieved a volume increase of 214.5% in the first seven months of this year. According to the DSM Group, this is the best dynamics among the top 100 manufacturers.
The company notes that such an increase in sales in the market is confirmed by Promomed's financial statements. Thus, in 2025, the company's revenue increased by 75%, and in the first half of 2026, the growth was 76% compared to the same period last year.Innovative drugs in the treatment of type 2 diabetes and obesity remain the key driver of the company's growth. According to the DSM Group, the first domestic tirzepatide became the No. 1 brand in terms of pharmacy sales in January and has held its position throughout the year. In addition to endocrinology, Promomed is actively developing areas of oncology and therapy against HIV infection. The company has recently completed the development cycle of innovative long-acting antiretroviral drugs that were previously unavailable in Russia.
"The data from analytical agencies clearly confirms the effectiveness of Promomed's strategy, based on the development and commercialization of the latest solutions in the most sought–after therapeutic areas,“ the company said in a statement.
The leadership in the DSM Group rating for seven months and the growth rate, several times ahead of the market, allow the company to achieve its goals, including reaching sales of more than 240 billion rubles by 2032.
Stay informed
Stay informed
Get the most interesting news and publications first!
Sent successfully!
Press office
To request a press release or interview, please contact our press office